<DOC>
	<DOCNO>NCT01932294</DOCNO>
	<brief_summary>Medamacs prospective , observational study ambulatory patient advance heart failure . The study enroll patient yet receive Left Ventricular Assist Device ( LVAD ) receive care hospital Joint Commission certify mechanical circulatory support program . Medamacs fund Interagency Mechanically Assisted Circulatory Support ( INTERMACS ) NHLBI Contract .</brief_summary>
	<brief_title>Medical Arm Interagency Registry Mechanically Assisted Circulatory Support</brief_title>
	<detailed_description>Participants 18 80 year old low ejection fraction history hospitalization heart failure within past year screen study . All subject admit heart failure service screen recruit , either inpatient first outpatient follow-up appointment investigator research staff care patient advanced heart failure program . Eligibility enrollment base upon information clinically available time screen . The history prior hospitalization available clinical record . Routine evaluation triage ambulatory patient advanced heart disease include echocardiography functional assessment peak oxygen consumption frequently 6 minute walk distance . The element information require estimation Seattle Heart Failure Risk score glean laboratory data , impute describe Seattle score literature . The research coordinator enter data onto currently available website calculation Seattle score . Eligibility determine inclusion exclusion criterion study research team approach individual subject potential candidate participation subject 's primary physician give permission approach . Only person scientific ethical reason exclude . Incarcerated prisoner exclude protocol . Participants follow every 6 month 24 month two baseline visit . The 6 month 18 month follow ups consist telephone interview . Follow up 12 month 24 month consist routine clinical visit . Approximately 350 patient 12 center United States enrol 12 month period .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure , Systolic</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients Advanced Heart Failure 1 . Age 1880 year 2 . New York Heart Association class IIIIV heart failure 45 last 60 day 3 . Left ventricular ejection fraction ≤ 35 % 4 . Heart failure diagnosis typical symptom 12 month 5 . Use evidence base oral medication ( betablockers , ACEinhibitors/ARBs , aldosterone antagonist ) least 3 month prior enrollment documented medication contraindication intolerance . 6 . Hospitalization heart failure within previous 12 month ( elective procedure ) 7 . Informed consent give In Addition , must least one follow : An additional unplanned hospitalization previous 12 month total least 2 inpatient hospitalization last &gt; 24 hour heart failure primary secondary diagnosis within previous 12 month OR 1 . Peak oxygen uptake ( VO2 ) &lt; 55 % age sexpredicted ( use Wasserman equation ) OR peak VO2 ≤16 ml/kg/min men ≤14 ml/kg/min woman test RER &gt; 1.08 cardiopulmonary exercise testing . 2 . 6minute walk distance &lt; 300 meter without noncardiac limitation . 3 . Serum BNP &gt; 1000 ( NTproBNP &gt; 4000 pg/ml ) outpatient hospital discharge . OR Seattle Heart Failure Model Score &gt; 1.5 . EXCLUSION CRITERIA : 1 . Age &gt; 80 year &lt; 18 year 2 . Noncardiac diagnosis anticipate limit 2year survival ( ≥3050 % mortality within 2 year noncardiac diagnosis ) 3 . Primary functional limitation noncardiac diagnosis even likely limit survival 4 . QRS &gt; 120msec plan biventricular pacemaker implant biventricular pacemaker implantation within past 90 day 5 . Current home intravenous inotrope therapy 6 . Chronic hemodialysis peritoneal dialysis 7 . Scheduled nonventricular assist device cardiac surgery current hospital admission 8 . Obvious anatomical major contraindication cardiac surgery future ( e.g . previous pneumonectomy , advance connective tissue disease ) 9 . Actively listed heart transplant UNOS Status 1 2 10 . History cardiac amyloidosis 11 . Dominant lesion least moderate aortic mitral stenosis congenital structural heart defect .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Advanced Heart Failure</keyword>
	<keyword>Refractory Heart Failure</keyword>
	<keyword>Mechanical Circulatory Support Device</keyword>
	<keyword>Ventricular Assist Device</keyword>
	<keyword>Medamacs</keyword>
</DOC>